We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Florida CMO Flagged by FDA for Unjustified Process Deviations
Florida CMO Flagged by FDA for Unjustified Process Deviations
September 4, 2012
Axara Pharmaceuticals has not justified deviations from process control procedures that resulted in drug products gone astray and equipment cleaning confusion, according to an FDA Form 483.